X   

Real-Time Quote

Enter Company or MF
   

Bafna Pharmaceuticals Ltd. - Research Center

532989  BAFNAPHAR  Group (T) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

(Rs crore)

Quarterly results in brief

 Sep ' 09Jun ' 09Mar ' 09Dec ' 08Sep ' 08
Sales 16.88 13.70 17.63 14.62 9.30
Operating profit 2.90 1.72 2.64 0.85 0.67
Interest 1.23 0.47 0.67 0.72 0.41
Gross profit 1.83 1.52 2.47 0.50 0.79
EPS (Rs) 0.77 0.60 1.15 -0.70 -0.15

Quarterly results in details

 Sep ' 09Jun ' 09Mar ' 09Dec ' 08Sep ' 08
Other income 0.16 0.27 0.50 0.38 0.53
Stock adjustment -3.11 -1.66 2.24 -1.24 1.12
Raw material 15.82 12.72 4.32 14.06 6.48
Power and fuel-----
Employee expenses 0.69 0.55 0.49 0.42 0.46
Excise-----
Admin and selling expenses-----
Research and development expenses-----
Expenses capitalised-----
Other expenses 0.59 0.37 7.94 0.52 0.58
Provisions made-----
Depreciation 0.44 0.43 -0.93 1.46 0.77
Taxation-- 1.41--
Net profit / loss 1.24 0.96 1.84 -1.11 -0.24
Extra ordinary item -0.15 -0.13 -0.15 -0.15 -0.26
Prior year adjustments-----
Equity capital 15.98 15.98 15.98 15.98 15.98
Equity dividend rate-----
Agg.of non-prom. shares (Lacs) 76.41 76.41 80.62 80.62 88.53
Agg.of non promotoholding (%) 47.81 47.81 50.45 50.45 55.39
OPM (%) 17.17 12.52 14.97 5.78 7.16
GPM (%) 10.71 10.87 13.64 3.33 8.07
NPM (%) 7.27 6.86 10.17 -7.43 -2.41